De-risk your real-world evidence-generation initiatives with Pulse Discovery
Overview
key partners and collaborators in primary research. This approach helps pharmaceutical companies answer important questions before starting a real world data initiative:
- How to secure early buy-in from PI and advocacy collaborators?
- Does the data we need already exist in registries or academic centers?
- What gaps in the existing data need to be addressed?
- How do we reduce upfront expenses on real-world research through a phased approach?
- What level of investment might be required to collect or generate that data?
- Would a retrospective and/or prospective approach work best?
- Should we consider site-based, patient-facing, or hybrid models?
Why Pulse Discovery?
Pulse Discovery evaluates real world evidence feasibility early in the research process. Based on this findings, we assess your study design, identify potential risks, and help determine whether available data can support your evidence needs.
Outcomes
Through Pulse Discovery, sponsors can draw on our 10+ years of experience to gain real world insights in as little as 3 months:
Directional Insight
Directional insights into conditions of interest, including related and secondary conditions
Assess Feasibility
Feasibility assessment for future real world research, including possible approaches and risk mitigation strategies
Party Alignment
Insight into the perspectives of leading PIs and advocacy groups in areas of interest
Identify Data Gaps
Clarity on the data landscape and the variables that would fill critical gaps
